Chelsea Therapeutics Rallies 30% Higher

Chelsea Therapeutics International

is trading higher on the session. There is speculation that a positive

spurred this rally. Just a few days ago, Chelsea Therapeutics fell over 50% after providing an update on Northera regulatory status. The company said that the FDA can't be confident certain info didn't influence amendment of statistical analytic plan and study 306B to support application for marketing approval of Northera in the U.S. Chelsea Therapeutics is currently trading at $1.18,a gain of $0.28 or 30.45%.